SPRINGWORKS THERAPEUTICS, INC. Shareholders' Equity
SPRINGWORKS THERAPEUTICS, INC. had Shareholders' Equity of $417.39 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-05-09
- 2025-03-31: Stockholders' Equity Attributable to Parent $417.39M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $481.10M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $532.58M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $556.73M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-03-31 | $417.39M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $481.10M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $532.58M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $556.73M 10-Q · filed 2024-11-12 |
| 2024-03-31 | $567.44M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $626.22M 10-Q · filed 2025-05-09 |
| 2023-09-30 | $394.90M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $451.44M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $506.92M 10-Q · filed 2024-08-07 |
| 2022-12-31 | $558.19M 10-K · filed 2025-02-20 |
| 2022-09-30 | $612.40M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $325.73M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $376.80M 10-Q · filed 2023-08-02 |
| 2021-12-31 | $422.40M 10-K · filed 2025-02-20 |
| 2021-09-30 | $466.68M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $496.58M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $534.70M 10-Q · filed 2022-08-04 |
| 2020-12-31 | $557.06M 10-K · filed 2024-02-27 |
| 2020-09-30 | $272.75M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $290.87M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $308.13M 10-Q · filed 2021-08-04 |
| 2019-12-31 | $322.07M 10-K · filed 2023-02-28 |
| 2019-09-30 | $337.32M 10-Q · filed 2020-11-12 |
| 2019-06-30 | -$33.66M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$20.46M 10-Q · filed 2020-08-12 |
| 2018-12-31 | -$19.37M 10-K · filed 2022-02-24 |
| 2017-12-31 | -$2.63M 10-K · filed 2021-02-25 |